Princeton Capital Management’s Mesoblast MESO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-91,957
Closed -$1.38M 114
2021
Q2
$1.38M Buy
91,957
+4,521
+5% +$71K 0.43% 50
2021
Q1
$1.45M Buy
87,436
+829
+1% +$15.7K 0.49% 49
2020
Q4
$1.47M Buy
86,607
+12,778
+17% +$315K 0.53% 46
2020
Q3
$2.74M Buy
73,829
+4,567
+7% +$143K 1.1% 28
2020
Q2
$1.58M Buy
69,262
+9,362
+16% +$200K 0.7% 39
2020
Q1
$1.41M Buy
59,900
+3,001
+5% +$46K 0.73% 36
2019
Q4
$1.09M Sell
56,899
-1,601
-3% -$20.4K 0.49% 41
2019
Q3
$811K Buy
58,500
+1,250
+2% +$13.8K 0.39% 45
2019
Q2
$608K Buy
57,250
+3,525
+7% +$37.2K 0.3% 56
2019
Q1
$564K Sell
53,725
-4,309
-7% -$39.3K 0.28% 57
2018
Q4
$478K Sell
58,034
-14,516
-20% -$166K 0.28% 56
2018
Q3
$1.18M Sell
72,550
-685
-0.9% -$8.69K 0.49% 39
2018
Q2
$806K Sell
73,235
-412
-0.6% -$4.71K 0.35% 48
2018
Q1
$851K Buy
73,647
+11,636
+19% +$140K 0.38% 46
2017
Q4
$724K Buy
+62,011
New +$701K 0.32% 52

Other funds holding MESO

Princeton Capital Management's MESO Position: Q3 2021 in Review

Princeton Capital Management sold out of Mesoblast (MESO) in Q3 2021, closing a stake of 91,957 shares — an estimated $1.38M sold.

Princeton Capital Management first reported a position in MESO in Q4 2017 and held it in 15 quarters. The position peaked at $2.74M in Q3 2020. 41 funds tracked by Wall St. Rank hold MESO as of Q3 2021.

  • Princeton Capital Management reported no remaining Mesoblast position as of Q3 2021 after selling out during the quarter.
  • Princeton Capital Management sold 91,957 Mesoblast shares in Q3 2021, an estimated $1.38M.
  • Princeton Capital Management first reported a position in Mesoblast in Q4 2017 and held it in 15 quarters.
  • Princeton Capital Management's Mesoblast position peaked at $2.74M in Q3 2020.
  • 41 funds tracked by Wall St. Rank held Mesoblast as of Q3 2021.

Based on Princeton Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.